WHO ICTRP trial
Clinical trial of CREPT-618 in the treatment of primary biliary cholangitis
ChiCTR2500109564 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500109564 |
|---|---|
| Public title | Clinical trial of CREPT-618 in the treatment of primary biliary cholangitis |
| Scientific title | Clinical trial of CREPT-618 in the treatment of primary biliary cholangitis |
| Primary sponsor | Deyang People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Primary Biliary Cholangitis |
| Interventions | Positive control group:Ursodeoxycholic acid capsules were orally administered daily for 84 consecutive days.;Test group 1:Subcutaneous injection of crept-618 once;Test group 2~5:Crept-618 was injected subcutaneously for 4 times |
| Registration date | Sep 22, 2025 |
| Target size | Positive control group:3;Test group 1:1;Test group 2~5:15 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: